A three-year, $15 million partnership between Cornell and NewYork-Presbyterian will employ artificial intelligence to help improve outcomes for people with cardiovascular disease.
Researchers have uncovered a novel pathway that explains how cancer cells become resistant to chemotherapies, which in turn offers a potential solution for preventing chemo-resistance.
Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified a previously unrecognized form of hormone therapy-resistant prostate cancer, as well as a set of molecules that drive its growth.
In Medellin, Colombia, low-income residents who lived in close proximity to new public transit stations had increased rates of mosquito-transmitted dengue fever, according to a new study.
New research from Cornell scientists is exploring how human genetics impacts functions of the gut microbiome, and is expanding awareness of the role human genetics plays in shaping the microbiome.
Hysteroscopic sterilization, a nonincisional procedure, was found to be as effective as minimally invasive laparoscopic sterilization in preventing pregnancy, but both methods had higher-than-expected failure rates, according to a new study led by an investigator at Weill Cornell Medicine.
As consumers want fewer food preservatives and less plastic waste, Cornell scientists have created a bioderived polymer that helps salad dressings and beverages last longer in the fridge.
A multidisciplinary team of Weill Cornell Medicine researchers has received a five-year $5.7 million grant from the National Cancer Institute at the National Institutes of Health to fund a center aimed at developing messenger RNA vaccines to deter cancer development in at-risk groups.
There is considerable variation in the management of mantle cell lymphoma across different clinical settings according to an analysis by investigators.
Concern is growing given the sluggish rollout of the coronavirus vaccination distribution in New York. Cynthia Leifer, associate professor of immunology at Cornell University, says vaccines need to be given quickly as possible and rather than disqualifying sites from getting future distributions, expanding the number of distribution locations and incentivizing rapid use is a better solution.
